Capricor Therapeutics (CAPR) Divestments (2013 - 2014)

Capricor Therapeutics (CAPR) recorded quarterly Divestments of -$94314.0 in Q1 2014, down 121.88% quarter-over-quarter from $431040.0 in Q1 2013, and down 121.88% on a YoY basis from $431040.0 in Q1 2013.

Capricor Therapeutics (CAPR) Divestments (2013 - 2014) Analysis & Trends

Capricor Therapeutics' Divestments history runs 2 years deep, the most recent figure standing at -$94314.0 for Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Capricor Therapeutics 1.53 Bn 1.26 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2014 -94,314.00
Mar 31, 2013 431,040.00